Literature DB >> 2871054

Cardiovascular and neuromuscular effects of esmolol during induction of anesthesia.

V S Murthy, K D Patel, R G Elangovan, T F Hwang, S M Solochek, J D Steck, A R Laddu.   

Abstract

Sixteen subjects scheduled for surgical procedures under general anesthesia participated in an investigation of the effects of esmolol on the transient hypertension and tachycardia that was observed during endotracheal intubation and on the duration of succinylcholine-induced neuromuscular blockade. In eight subjects, infusion of esmolol was begun five minutes before induction of anesthesia and continued for 12 minutes after induction. In the remaining subjects, an equivalent volume of solvent (D5W) was infused for 12 minutes. Infusion of esmolol significantly attenuated the cardioacceleration observed during intubation without any significant effect on the pressor effects of the procedure. Esmolol delayed the recovery from succinylcholine-induced neuromuscular blockade by less than three minutes. The mechanism of this delay remains to be investigated, although such a delay does not have clinical significance. Esmolol-induced attenuation of the tachycardia seen during intubation may offer a protective effect on the myocardium, especially in elderly subjects and patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871054     DOI: 10.1002/j.1552-4604.1986.tb03537.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  3 in total

1.  Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian Multicentre Trial.

Authors:  D R Miller; R J Martineau; J E Wynands; J Hill
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

2.  Effect of landiolol hydrochloride on suxamethonium-induced neuromuscular block.

Authors:  Takahiro Suzuki; Mayu Aono; Tomomi Isaka; Eri Miyake; Naoko Fukano; Shigeru Saeki; Setsuro Ogawa
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

Review 3.  Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P Benfield; E M Sorkin
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.